| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Chief Financial Officer
1 company
Robb Gary Charles is a Chief Business Officer at CORCEPT THERAPEUTICS INC. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $9.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2021 | CORT Corcept Therapeutics Inc | Chief Financial Officer | Sell | 115,500 | $28.27 | $3,265,148.13 | -29.0% | |
| Dec 9, 2019 | CORT Corcept Therapeutics Inc | Chief Financial Officer | Sale+OE | 30,000 | $13.73 | $412,029.00 | -78.9% | |
| Dec 12, 2018 | CORT Corcept Therapeutics Inc | Chief Financial Officer | Sale+OE | 25,000 | $19.01 | $475,152.50 | -78.5% | |
| May 4, 2017 | CORT Corcept Therapeutics Inc | Chief Financial Officer | Buy | 5,600 | $9.75 | $54,588.24 | +445.2% |